Indication
Post COVID-19 Syndrome
2 clinical trials
1 product
Clinical trial
Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of HB-adMSCs for the Treatment of Patients With Post-COVID-19 SyndromeStatus:
Product
HB-adMSCsClinical trial
A Randomized, Double-blinded, Single-center, Phase 2 Efficacy, and Safety Study of Allogeneic HB-adMSCs for the Treatment of Patients With Chronic Post-COVID-19 Syndrome.Status: Completed, Estimated PCD: 2024-04-02